Loading company details…
Dermocore is a pharmaceutical manufacturing company that develops and produces products focused on s Sign up to read more
Profile updated Aug 2026
No share issues or funding rounds.
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| JAMAL BAKER | GOLDEN SHARE, ORDINARY | 109 | 98.2% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
2 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity DERMOCORE LTD. raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
These are the directors and secretaries who have left DERMOCORE LTD.. A resignation is filed with Companies House on form TM01 and the date below is the date the officer's appointment ended, not the date it was filed. Departures matter for reading a company's history: a founder leaving shortly after a funding round, or several directors resigning at once, is often the visible trace of a change of control or a restructure.